MVF.ASX: NBIO withdrawn to acquire Monash IVF

NBIO withdrawn to acquire Monash IVF

Stock	Monash Ivf Group Ltd (MVF.ASX)
Release Time	24 Dec 2025, 8:54 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Consortium withdraws proposal to acquire Monash IVF

Key Points

Consortium comprising Genesis Capital and WHSP Holdings withdraws non-binding indicative proposal
Proposal was to acquire 100% of Monash IVF shares at $0.80 per share
Monash IVF will inform shareholders of any material developments in the future

Full Summary

Monash IVF Group Limited (ASX:MVF) has received correspondence from the consortium comprising Genesis Capital Investment Management Pty Ltd ('Genesis Capital' or 'Genesis') and WHSP Holdings Pty Limited ('Soul Patts') (together, the 'Consortium') withdrawing the Consortium's non-binding indicative proposal to acquire 100% of the shares in Monash IVF at $0.80 per share by way of a Scheme of Arrangement ('Proposal'). The announcement comes further to the ASX release dated 24 November 2025, where Monash IVF had initially received the Consortium's non-binding indicative proposal. Monash IVF has stated that if there are any material developments in the future, the company will inform shareholders as required under its continuous disclosure obligations.